Early response to Tezepelumab in type-2 severe asthma patients non-responders to other biological treatments: a real-life study. Jimenez-Gomez M, Diaz-Campos RM, Gimeno-Diaz-De-Atauri A, Fernandez-Rodriguez C, et al. J Asthma 2024 Apr 30:1-7. doi: 10.1080/02770903.2024.2349605.

Read + Share

Amedeo Smart

Independent Medical Education

Jimenez-Gomez M, Diaz-Campos RM, Gimeno-Diaz-De-Atauri A, Fernandez-Rodriguez C, et al. Early response to Tezepelumab in type-2 severe asthma patients non-responders to other biological treatments: a real-life study. J Asthma 2024 Apr 30:1-7. doi: 10.1080/02770903.2024.2349605.
PMID: 38686823